The diagnosis and management of a heterokaryotypic monochorionic pregnancy, in which one of twins had trisomy 13, is presented. Monozygosity and discordant karyotypes were confirmed by amniocentesis of both the sacs. Radiofrequency ablation of the trisomic twin was successfully performed at 18-weeks gestation and the pregnancy ended at term with the birth of a healthy girl who remains well on follow-up at 12 months of age. We reiterate the importance of early amniocentesis of both the sacs in the presence of discordant fetal abnormalities and consideration of selective fetal termination to optimise the outcome of heterokaryotypic monochorionic twin pregnancies.
Introduction
Traditionally, monozygotic twins have been assumed to be genetically identical. As evidence of phenotypic and genotypic discordance between monozygotic twins has accumulated, there have been calls to abandon the use of the term 'identical' to describe these twins. 1 A recent review has summarised the literature on monozygotic twins discordant for Mendelian inherited disorders and chromosomal abnormalities. 2 We report a case of monozygotic twins discordant for trisomy 13 and highlight important counselling and management issues.
Case
A 39-year-old woman, gravida 4, para 1 with two previous miscarriages, attended for a dating scan at 12 weeks of gestation in a spontaneous pregnancy. The scan revealed a monochorionic, diamniotic pregnancy with two viable fetuses and increased nuchal thickness of 7.5 mm in one of the twins. Monochorionicity was confirmed on ultrasound scan. 3 Nuchal thickness in the first twin (twin A) was normal at 0.8 mm and no structural malformations were identified. Detailed scan of the second twin (twin B) showed alobar holoprosencephaly and a proboscis. In view of this marked discrepancy, amniocentesis of both the sacs was performed at 15 þ 2 weeks of gestation to check the zygosity and karyotype of both the twins. A scan at this gestation identified further abnormalities in the second twin including a common atrioventricular valve, bilateral mild hydrothorax and hyperechoic kidneys. Initial Quantitative Fluorescent-PCR analysis showed trisomy 13 (47, XX, þ 13) in twin B and this was confirmed on long-term culture of amniocytes. The karyotype of twin A was normal (46, XX). Monozygosity was confirmed by molecular analysis using the markers D16S539, D7S820, D13S317, D5S818, CFS1PO, TPOX, THO1, vWA and AMEL (PowerPlex 1.2 system, Promega, Madison, WI).
The couple had detailed counselling from the fetal medicine specialist and a clinical geneticist. Options included conservative management, termination of the entire pregnancy and referral for selective termination. The outcome of trisomy 13 pregnancies was reviewed, alongside the risks of spontaneous intrauterine fetal demise of the abnormal twin, with its associated risk to the co-twin, and of course the risk of miscarriage following a selective termination. Radiofrequency ablation of twin B was performed at 18 weeks of gestation. Ultrasound scan 2 days after the procedure showed no cardiac activity or blood flow through twin B, while twin A appeared normal. A fetal magnetic resonance imaging scan was performed at 22 weeks, on the advice of the specialist performing the termination, to help exclude the possibility of ischaemic brain injury, which may be sustained by the surviving twin during a laser ablation procedure. This showed normal brain morphology. The subsequent course of the pregnancy was uneventful and a healthy baby girl, weighing 3.94 kg (75th centile), was born after induction of labour at 39 þ 4 weeks. Her examination in the genetics clinic at 3 months age was normal. She is now 12 months old and continues to grow and develop normally.
Discussion
Several genetic mechanisms, including postzygotic mitotic errors leading to mosaicism, skewed X-chromosome inactivation and postzygotic dominant or recessive gene mutations, have been associated with genotypic differences between monozygotic twins. 1 More recently, interest has focussed on the role of epigenetic mechanisms, independently and in conjunction with the artificial reproductive techniques, in the origin of monozygotic twins. 4 The frequency of heterokaryotypic twinning has been difficult to estimate. If same-sex dichorionic, but monozygotic, twins have discordant karyotypes, they may be erroneously assumed to be dizygotic. Moreover, a proportion of monozygotic twins with an abnormal karyotype probably suffer early fetal demise. Nevertheless, heterokaryotypic monozygotic twinning is a rare occurrence, and most reports in the medical literature concern monochorionic twins discordant for Turner syndrome (45, X). 5, 6 There are only four reports of monochorionic twins discordant for trisomy 13.
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The mechanism of occurrence of monozygotic twins has been discussed by various authors, 4,10 but little is known about the mechanisms underlying heterokaryotypic twinning. Parent of origin studies in our case indicated maternal origin of the trisomic chromosome. The normal twin was shown to have inherited the same maternal and paternal microsatellite markers as the trisomic twin, but present as a 1:1 ratio, rather than the 2:1 ratio in the trisomic twin. This finding may be explained by an early trisomic rescue event with loss of the maternal (trisomic) chromosome from one of trisomic (twin) zygotes, or an early postzygotic nondisjunction of the maternal chromosome from a normal (twin) zygote. It is possible that twin B or even both the twins were actually mosaic for trisomy 13, and amniocentesis may not have identified the mosaicism. As twin A did not show any congenital anomalies and remains well on follow-up, we have not checked her postnatal karyotype.
An argument has been presented for sampling of a single amniotic sac in a monochorionic twin pregnancy at elevated risk of Down syndrome, making the assumption that both the fetuses will have the same chromosome makeup. Support for this approach comes from evidence suggesting a higher rate of procedure-related miscarriage in twin pregnancies, compared with singletons. However, as demonstrated by this case, it is important to perform amniocentesis of both the sacs for the determination of karyotype and zygosity in monochorionic diamniotic twins discordant for fetal abnormalities on ultrasound. This option has been advocated by other authors as well. 6 A chorionic villus sample in this situation may provide a false negative (normal karyotype) result in an aneuploid fetus, 6, 11 and sampling a single amniotic sac will not exclude the possibility of aneuploidy in the second fetus. Early decision to perform amniocentesis in both the fetuses in our case resulted in timely diagnosis and allowed for thorough counselling before referral for selective fetal termination.
The excess risk of spontaneous fetal death (90% confidence intervals) has been estimated at 36.5% (11-69.7%) in trisomy 13 fetuses. 12 If the trisomic fetus happens to be one of monochorionic twins, this risk would probably be even higher. The risks of death or neurological injury in the co-twin have been estimated to be 12% and 18%, respectively, after the death of one twin in a monochorionic pregnancy. 13 Before the availability of procedures for selective fetal termination, expectant management was the only option. More recently, good results after selective fetal termination using bipolar or laser cord coagulation have been described. 6 The risk of co-twin death/pregnancy loss and brain injury after single intrauterine death in monochorionic pregnancies has been estimated by O'Donoghue et al.
14 Pregnancies in which single intrauterine death was spontaneous, occurred after fetoscopic placental laser, or resulted from selective termination by bipolar diathermy cord occlusion or interstitial laser were included in the study. The overall risks for co-twin loss and antenatal brain injury were estimated as 22.9% and 7.7%, respectively. There was no significant difference in incidence of miscarriage or co-twin death when comparing procedure related and spontaneous intrauterine deaths but the risk of brain abnormality on imaging was significantly higher after spontaneous intrauterine death. Radiofrequency ablation was used in our case for selective termination. This technique has been shown to be safe and effective for fetal reduction in a series of 35 complicated monochorionic pregnancies, with only one miscarriage (2.9%) within 2 weeks of the procedure. 15 There were two stillbirths (5.7%), 5 and 10 weeks after the procedure, respectively, but no cause of demise was apparent on postmortem. There were two cases (5.7%) of abnormal brain magnetic resonance imaging following radiofrequency ablation, but both the cases did not fit the typical hypotensive brain injuries usually seen in the surviving twin. Overall, initial data suggests that radiofrequency ablation is a promising technique for fetal reduction in monochorionic pregnancies and compares favourably with other vaso-occlusive techniques.
Conclusion
We report successful management of a case of a monozygotic pregnancy discordant for trisomy 13. We reinforce the importance of amniocentesis of both the sacs in the presence of discordant fetal abnormalities and early consideration of selective fetal termination to optimise the outcome of heterokaryotypic monozygotic pregnancies.
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